Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Cancer Research
|
April 29, 2010
Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma
Daniel Muth, Seda Ghazaryan, Isabella Eckerle, et al.
Genome Biology
|
October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann, Daniel Muth, Axel Benner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2007
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status
Frank Westermann, Kai-Oliver Henrich, Jun S Wei, et al.
Cancers
|
November 25, 2020
Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation
Ana Colmenero-Repiso, María A Gómez-Muñoz, Ismael Rodríguez-Prieto, et al.
Molecular Oncology
|
November 25, 2015
Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma
Fakhera Ikram, Sandra Ackermann, Yvonne Kahlert, et al.
International Journal of Cancer
|
October 27, 2006
Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias
Evgeny N Suspitsin, Anna P Sokolenko, Alexandr V Togo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2021
FOXR2 Stabilizes MYCN Protein and Identifies Non-<i>MYCN</i>-Amplified Neuroblastoma Patients With Unfavorable Outcome
Felix Schmitt-Hoffner, Sjoerd van Rijn, Umut H Toprak, et al.
Human Molecular Genetics
|
August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas
Daniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
Nature Genetics
|
March 26, 2021
Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma
Selina Jansky, Ashwini Kumar Sharma, Verena Körber, et al.
Oncotarget
|
August 18, 2016
Wnt signalling is a bi-directional vulnerability of cancer cells
David J Duffy, Aleksandar Krstic, Thomas Schwarzl, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Cancer Research
|
April 29, 2010
Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma
Daniel Muth, Seda Ghazaryan, Isabella Eckerle, et al.
Genome Biology
|
October 15, 2008
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
Frank Westermann, Daniel Muth, Axel Benner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2007
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status
Frank Westermann, Kai-Oliver Henrich, Jun S Wei, et al.
Cancers
|
November 25, 2020
Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation
Ana Colmenero-Repiso, María A Gómez-Muñoz, Ismael Rodríguez-Prieto, et al.
Molecular Oncology
|
November 25, 2015
Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma
Fakhera Ikram, Sandra Ackermann, Yvonne Kahlert, et al.
International Journal of Cancer
|
October 27, 2006
Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias
Evgeny N Suspitsin, Anna P Sokolenko, Alexandr V Togo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2021
FOXR2 Stabilizes MYCN Protein and Identifies Non-<i>MYCN</i>-Amplified Neuroblastoma Patients With Unfavorable Outcome
Felix Schmitt-Hoffner, Sjoerd van Rijn, Umut H Toprak, et al.
Human Molecular Genetics
|
August 9, 2014
p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas
Daniel Dreidax, Steffen Bannert, Kai-Oliver Henrich, et al.
Nature Genetics
|
March 26, 2021
Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma
Selina Jansky, Ashwini Kumar Sharma, Verena Körber, et al.
Oncotarget
|
August 18, 2016
Wnt signalling is a bi-directional vulnerability of cancer cells
David J Duffy, Aleksandar Krstic, Thomas Schwarzl, et al.
Page
of 5